Psilocybin could soon help millions of people tackle obesity and eating disorders. At the moment, the global obesity epidemic is still bursting at the seams. According to the World Health Organization (WHO) obesity has tripled in size over the last 50 years. In 2016, they note, 1.9 billion adults were overweight around the world. Of those, 650 million were considered obese. Just in the U.S., nearly 34% of adults and up to 20% of children are obese. By 2030, almost half of U.S. adults will be considered obese. By 2030, almost half of U.S. adults will be considered obese. Along with such weight issues, there can be complications with heart disease, stroke, type 2 diabetes, and several types of cancer. However, a solution may be found in psychedelics such as psilocybin, which activates serotonin receptors, or “nature’s own appetite suppressant,” as noted by Psychology Today. “This powerful brain chemical curbs cravings and shuts off appetite. It makes you feel satisfied even if your stomach is not full. The result is eating less and losing weight.” With the story gaining big momentum, some of the top companies to keep an eye on include NeonMind Biosciences Inc. (CSE: NEON), HAVN Life Sciences Inc. (CSE:HAVN), Cybin Inc. (NEO:CYBN)(OTC:CLXPF), Tryp Therapeutics Inc. (CSE:TRYP), and Mind Medicine Inc. (NEO:MMED)(OTC:MMEDF).
…
Dr. Birmingham is an expert in the treatment and study of eating and weight disorders. He has pioneered several new internationally recognized treatments. He has more than 30 years of experience in eating disorder and obesity research and treatment and has 280 publications including 131 referenced articles, 23 invited chapters, and 9 books. He was Head of General Internal Medicine at St. Paul’s Hospital and UBC, Head of the Obesity Clinic at St. Paul’s Hospital, Leader of the BC Eating Disorders Epidemiology Project in the Centre for Health Evaluation and Outcome Sciences, BC Provincial Director of Eating Disorders, and Medical Director of the Woodstone Residential Treatment Centre for Eating Disorders. He is a Member of the Brain Research Centre at UBC.
Click here for the full story on Baystreet.ca
